[HTML][HTML] Cortical beta amyloid protein triggers an immune response, but no synaptic changes in the APPswe/PS1dE9 Alzheimer's disease mouse model

KTS Wirz, K Bossers, A Stargardt, W Kamphuis… - Neurobiology of …, 2013 - Elsevier
Using microarray technology we studied the genome-wide gene expression profiles in the
frontal cortex of APPswe/PS1dE9 mice and age and sex-matched littermates at the age of 2 …

Hippocampal neuron loss exceeds amyloid plaque load in a transgenic mouse model of Alzheimer's disease

C Schmitz, BPF Rutten, A Pielen, S Schäfer… - The American journal of …, 2004 - Elsevier
According to the “amyloid hypothesis of Alzheimer's disease,” β-amyloid is the primary
driving force in Alzheimer's disease pathogenesis. Despite the development of many …

APP transgenic mice: their use and limitations

C Balducci, G Forloni - Neuromolecular medicine, 2011 - Springer
Alzheimer's disease is the most widespread form of dementia. Its histopathological
hallmarks include vascular and extracellular β-amyloid (Aβ) deposition and intraneuronal …

Mouse models of Alzheimer's disease: the long and filamentous road

AL Phinney, P Horne, J Yang, C Janus… - Neurological …, 2003 - Taylor & Francis
Alzheimer's disease (AD) is characterized by memory impairment leading to dementia,
deposition of amyloid plaques and neurofibrillary tangles (NFTs), and neuronal loss. The …

[HTML][HTML] The two faces of synaptic failure in AppNL-GF knock-in mice

A Latif-Hernandez, V Sabanov, T Ahmed… - Alzheimer's research & …, 2020 - Springer
Background Intensive basic and preclinical research into Alzheimer's disease (AD) has
yielded important new findings, but they could not yet been translated into effective …

Plaques, tangles, and memory loss in mouse models of neurodegeneration

JL Eriksen, CG Janus - Behavior genetics, 2007 - Springer
Within the past decade, our understanding of the pathogenic mechanisms in Alzheimer's
disease (AD) has dramatically advanced because of the development of transgenic mouse …

[HTML][HTML] Behavioral and neural network abnormalities in human APP transgenic mice resemble those of App knock-in mice and are modulated by familial Alzheimer's …

ECB Johnson, K Ho, GQ Yu, M Das… - Molecular …, 2020 - Springer
Background Alzheimer's disease (AD) is the most frequent and costly neurodegenerative
disorder. Although diverse lines of evidence suggest that the amyloid precursor protein …

Amyloid pathology is associated with progressive monoaminergic neurodegeneration in a transgenic mouse model of Alzheimer's disease

Y Liu, MJ Yoo, A Savonenko, W Stirling… - Journal of …, 2008 - Soc Neuroscience
β-Amyloid (Aβ) pathology is an essential pathogenic component in Alzheimer's disease
(AD). However, the significance of Aβ pathology, including Aβ deposits/oligomers and glial …

[HTML][HTML] Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Aβ and synaptic dysfunction

S Oddo, A Caccamo, JD Shepherd, MP Murphy… - Neuron, 2003 - cell.com
The neuropathological correlates of Alzheimer's disease (AD) include amyloid-β (Aβ)
plaques and neurofibrillary tangles. To study the interaction between Aβ and tau and their …

[HTML][HTML] Transgenic APP expression during postnatal development causes persistent locomotor hyperactivity in the adult

SP Rodgers, HA Born, P Das, JL Jankowsky - Molecular …, 2012 - Springer
Background Transgenic mice expressing disease-associated proteins have become
standard tools for studying human neurological disorders. Transgenes are often expressed …